Imidazopyrazines as cyclin dependent kinase inhibitors
    15.
    发明授权
    Imidazopyrazines as cyclin dependent kinase inhibitors 失效
    咪唑吡嗪作为细胞周期蛋白依赖性激酶抑制剂

    公开(公告)号:US07432265B2

    公开(公告)日:2008-10-07

    申请号:US11047524

    申请日:2005-01-31

    IPC分类号: C07D487/04 A61K31/495

    CPC分类号: C07D487/04

    摘要: In its many embodiments, the present invention provides a novel class of imidazo[1,2-a]pyrazine compounds as inhibitors of cyclin dependent kinases, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of preparing pharmaceutical formulations comprising one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more diseases associated with the CDKs using such compounds or pharmaceutical compositions.

    摘要翻译: 在其许多实施方案中,本发明提供了一类新颖的咪唑并[1,2-a]吡嗪化合物作为细胞周期蛋白依赖性激酶的抑制剂,制备此类化合物的方法,含有一种或多种此类化合物的药物组合物,制备药物制剂的方法 包括一种或多种这样的化合物,以及使用这些化合物或药物组合物治疗,预防,抑制或改善与CDK相关的一种或多种疾病的方法。